PATENT CLAIM ANALYSIS

Application Number: 15925260
Application Type: Utility
Filing Date: 2018-03
Publication Date: 2018-07
Patent Classification: ["424", "001110"]

Abstract:
The invention is directed to a method for preventing nasolacrimal duct obstruction (NLDO) in a patient receiving high dose radioactive iodine for treatment of cancer. The method includes administering an effective amount of perchlorate anion to the eyes of the patient.

Claim (Index 3):
The method of  claim 2 , wherein the patient receiving radioactive iodine is receiving the radioactive iodine for treatment of cancer.

Metadata:
- Claim Count in Document: 32.0
- Percentile: 90.0
- Lexical Diversity: 1.28571
- Patent Class: 424.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['11112553', '14225087', '12012469', '13962509', '15099034']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8286579416665422
- 35 USC 102 Novelty (BERT): 0.5679143674492619
- Combined Prediction Score: 0.8025835842448141
- Mean Citation Score: 500.130458
- Max Citation Score: 507.59644
- Similarity Product: 341.95000970834485

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test